156 related articles for article (PubMed ID: 8091462)
1. The risk of alloimmunization to c (Rh4) in R1R1 patients who present with anti-E.
Shirey RS; Edwards RE; Ness PM
Transfusion; 1994 Sep; 34(9):756-8. PubMed ID: 8091462
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
3. Absence of D- alloimmunization in AIDS patients receiving D-mismatched RBCs.
Boctor FN; Ali NM; Mohandas K; Uehlinger J
Transfusion; 2003 Feb; 43(2):173-6. PubMed ID: 12559012
[TBL] [Abstract][Full Text] [Related]
4. Frequency of alloimmunization to c (Rh4) in R1R1 patients presenting with anti-E.
Swanson JL
Transfusion; 1996 Jan; 36(1):85. PubMed ID: 8607163
[No Abstract] [Full Text] [Related]
5. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
Schonewille H; Brand A
Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
[TBL] [Abstract][Full Text] [Related]
6. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia.
Hussein E; Ahmed Eldesoukey N; Rihan A; Kamal A
Arch Pathol Lab Med; 2014 May; 138(5):684-8. PubMed ID: 24786127
[TBL] [Abstract][Full Text] [Related]
7. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Cox JV; Steane E; Cunningham G; Frenkel EP
Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
[TBL] [Abstract][Full Text] [Related]
8. Relevance of RH variants in transfusion of sickle cell patients.
Noizat-Pirenne F; Tournamille C
Transfus Clin Biol; 2011 Dec; 18(5-6):527-35. PubMed ID: 22024128
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Rh anti-E and anti-c production among Japanese after blood transfusion.
Komatsu F
Bull Tokyo Med Dent Univ; 1988 Sep; 35(3):75-9. PubMed ID: 3148374
[TBL] [Abstract][Full Text] [Related]
10. [Fetomaternal anti-RH3, -4 (anti-E and anti-c) rhesus isoimmunization: a case report].
Farnault L; Garcia-Meric P; Cortey A; Arnaud F
Arch Pediatr; 2011 Feb; 18(2):176-82. PubMed ID: 21194903
[TBL] [Abstract][Full Text] [Related]
11. An immediate hemolytic transfusion reaction due to anti-C and a delayed hemolytic transfusion reaction due to anti-Ce+e: hemoglobinemia, hemoglobinuria and transient impaired renal function.
Molthan L; Matulewicz TJ; Bansal-Carver B; Benz EJ
Vox Sang; 1984; 47(5):348-53. PubMed ID: 6438912
[TBL] [Abstract][Full Text] [Related]
12. D+ platelet transfusions in D- patients: cause for concern?
Bartley AN; Carpenter JB; Berg MP
Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
[TBL] [Abstract][Full Text] [Related]
13. On a much higher than reported incidence of anti-c in R1R1 patients with anti-E.
Judd WJ; Dake LR; Davenport RD
Immunohematology; 2005; 21(3):94-6. PubMed ID: 16178665
[TBL] [Abstract][Full Text] [Related]
14. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
Irani MS; Karafin MS; Ernster L
J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
[TBL] [Abstract][Full Text] [Related]
15. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
16. The Rh blood group system and its role in alloimmunization rate among sickle cell disease and sickle thalassemia patients in Iran.
Jalali Far MA; Oodi A; Amirizadeh N; Mohammadipour M; Keikhaei Dehdezi B
Mol Genet Genomic Med; 2021 Mar; 9(3):e1614. PubMed ID: 33547762
[TBL] [Abstract][Full Text] [Related]
17. [Identification of alloantibodies and their associations: Balance sheet of 3 years at the Regional Center of Blood Transfusion in Rabat/Morocco and difficult in transfusion management].
Achargui S; Zidouh A; Abirou S; Merhfour FZ; Monsif S; Amahrouch S; El Ghobre A; El Halhali M; Temmara H; El Hryfy A; Motqi M; Satty A; Kandili M; Aghri M; Hajjout K; Benajiba M
Transfus Clin Biol; 2017 Nov; 24(4):422-430. PubMed ID: 28576386
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.
Shirey RS; Boyd JS; Parwani AV; Tanz WS; Ness PM; King KE
Transfusion; 2002 Nov; 42(11):1435-41. PubMed ID: 12421216
[TBL] [Abstract][Full Text] [Related]
19. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization.
Tournamille C; Meunier-Costes N; Costes B; Martret J; Barrault A; Gauthier P; Galactéros F; Nzouékou R; Bierling P; Noizat-Pirenne F
Transfusion; 2010 Jan; 50(1):13-9. PubMed ID: 19778340
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
Lin Y; Saskin A; Wells RA; Lenis M; Mamedov A; Callum J; Buckstein R
Vox Sang; 2017 Jan; 112(1):79-86. PubMed ID: 28097704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
